WithdrawnNCT03216356

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

Medication studyAges 18+United States

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Boston, United StatesSee all locations and recruitment
Activities: Behavioural activities described in the protocol · Medication described in the protocol · Placebo described in the protocol; its role is not resolved here
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateSeptember 2016

Recruitment status: Withdrawn
Enrollment listed in the registry: 0
Sponsor: Boston University Charles River Campus
Sponsor type: University
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Phase 2, Phase 3
Locations: United States
Age range: Over 18 Years
Official registry ID: NCT03216356
Official title: Show the full official title
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Withdrawn

Boston

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Boston University Charles River Campus, a university.

Does this study involve medication?

Yes. The study involves medication, including D-Cycloserine, Placebo and Study Pill.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.